Edward Orton

Ph.D. organic chemist with 20 year's experience in pharma discovery research focused on candidate optimization for effective PK/PD performance in vivo. Well-versed in biopharmaceutics aspects of drug delivery technologies. Methods for altering PK for enhanced efficacy, reduced toxicity, etc. Strenghtening IP position for NCEs through advanced formulation techniques.